Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors.
We bring the accuracy and sensitivity of our immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. We are also committed to translating immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.
immunoSEQ® PLATFORM
TECHNOLOGY
Learn how to identify millions of
T- and B-cell receptors in a single sample.
in the news
August 23, 2016
features
A Nature Conference: Immune Profiling in Health and Disease
This 2nd annual conference brings together leading scientists to discuss vaccine design, microbiome-host interactions, technological advances and the clinical and research applications that can arise from immunosequencing.
